A Phase I/II Study of AGA111 for Lumbar Interbody Fusion in Patients With Degenerative Disc Disease

NCT05574543 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease

Interventions

DRUG: AGA111
DRUG: Placebo

Sponsor

Angitia Biopharmaceuticals